18-33578460-CGCCGCCGCCGCCG-C
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_030632.3(ASXL3):c.-171_-159del variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.013 ( 3 hom., cov: 0)
Consequence
ASXL3
NM_030632.3 5_prime_UTR
NM_030632.3 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.878
Genes affected
ASXL3 (HGNC:29357): (ASXL transcriptional regulator 3) This gene encodes a protein containing a plant homeodomain (PHD) zinc finger domain that plays a role in the regulation of gene transcription. The encoded protein has been shown to negatively regulate lipogenesis by binding to and inhibiting the transcriptional activity of two nuclear hormone receptors, oxysterols receptor LXR-alpha (LXRalpha) and thyroid hormone receptor beta (TRbeta). The encoded protein may also inhibit histone deubiquitination. Mutations in this gene have been identified in human patients with Bainbridge-Ropers syndrome, which is characterized by feeding difficulties, developmental delay and other features. [provided by RefSeq, May 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 18-33578460-CGCCGCCGCCGCCG-C is Benign according to our data. Variant chr18-33578460-CGCCGCCGCCGCCG-C is described in ClinVar as [Likely_benign]. Clinvar id is 1199636.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0133 (301/22630) while in subpopulation AFR AF= 0.0356 (273/7672). AF 95% confidence interval is 0.0321. There are 3 homozygotes in gnomad4. There are 132 alleles in male gnomad4 subpopulation. Median coverage is 0. This position pass quality control queck.
BS2
High AC in GnomAd4 at 301 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ASXL3 | NM_030632.3 | c.-171_-159del | 5_prime_UTR_variant | 1/12 | ENST00000269197.12 | ||
ASXL3 | XM_005258356.2 | c.-171_-159del | 5_prime_UTR_variant | 1/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ASXL3 | ENST00000269197.12 | c.-171_-159del | 5_prime_UTR_variant | 1/12 | 5 | NM_030632.3 | P4 | ||
ASXL3 | ENST00000681521.1 | c.-171_-159del | 5_prime_UTR_variant | 1/11 | A2 | ||||
ASXL3 | ENST00000696964.1 | c.-171_-159del | 5_prime_UTR_variant | 1/13 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0133 AC: 300AN: 22628Hom.: 3 Cov.: 0
GnomAD3 genomes
AF:
AC:
300
AN:
22628
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0133 AC: 301AN: 22630Hom.: 3 Cov.: 0 AF XY: 0.0119 AC XY: 132AN XY: 11090
GnomAD4 genome
AF:
AC:
301
AN:
22630
Hom.:
Cov.:
0
AF XY:
AC XY:
132
AN XY:
11090
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 26, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at